Ocular Therapeutix, Inc. (OCUL) Social Stream



Ocular Therapeutix, Inc. (OCUL): $4.21

0.12 (+2.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add OCUL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Ocular Therapeutix Inc (OCUL) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Ocular Therapeutix Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 7 $33 $14 $22.714 $5.01 353.37%
2022-03-02 6 $30 $14 $20.833 $5.01 315.83%

The Trend in the Analyst Price Target


Over the past 21 months, OCUL's average price target has gone up $8.83.

OCUL reports an average of 135% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 4 30 15 25.500 15.455 65%
2021-07-17 4 30 15 25.330 12.210 107.45%
2021-09-11 7 33 15 24.430 10.870 124.75%
2021-09-19 7 33 15 23.430 10.550 122.09%
2021-11-10 5 30 14 21.714 7.230 200.33%

OCUL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 5 0 1 0 0 6

The Trend in the Broker Recommendations


OCUL's average broker recommendation rating improved by 0.5 over the prior 15 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how Ocular Therapeutix Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 467.38% of that group.
  • Ocular Therapeutix Inc's variance in analysts' estimates is lower than -327.77% of all US stocks.
  • In the context of stocks in the small market cap category, Ocular Therapeutix Inc's number of analysts covering the stock is greater than 401.23% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, Ocular Therapeutix Inc's average analyst price target is higher than 175.13% of them.

Stocks similar to Ocular Therapeutix Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are OBSV, NXTC, and NWBO.

Is OCUL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4741 seconds.